Record of Decision for Adoption of Nuclear Regulatory Commission's (NRC) Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, 15565-15566 [2024-04397]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
Request for information;
extension of comment period.
ACTION:
On February 9, 2024, the U.S.
Department of Energy (DOE) published
a request for information (RFI) seeking
comment on a notional Manufacturing
Capital Connector (MCC) to support
applicants seeking clean energy
manufacturing funding opportunities
and/or tax credits. The RFI established
a March 4, 2024, deadline for the
submission of written comments. DOE
is extending the comment period to
March 15, 2024.
DATES: The comment period for the RFI
published on February 9, 2024 (89 FR
9132) is extended. DOE will accept
comments responding to this RFI
submitted on or before March 15, 2024.
ADDRESSES: Interested parties may
submit comments electronically to
CapitalConnector-RFI@hq.doe.gov.
FOR FURTHER INFORMATION CONTACT:
Questions may be addressed to Rachel
Gould, CapitalConnector-RFI@
hq.doe.gov or (202) 586–6116.
SUPPLEMENTARY INFORMATION: On
February 9, 2024, the U.S. Department
of Energy (DOE) published a request for
information (RFI) in the Federal
Register (89 FR 9132). DOE issued this
RFI to gauge interest in, and invite input
on the design of, a notional
Manufacturing Capital Connector (MCC)
that would support applicants seeking
clean energy manufacturing funding
opportunities and/or tax credits. To
help inform the interest in and design
of the MCC for clean energy
manufacturing programs, DOE is
seeking public input on the potential
structure, benefits, and risks of the
proposed MCC from potential capital
providers and clean energy
manufacturing program applicants or
selectees. The RFI specifically welcomes
comment in response to a series of
questions aimed at applicants or
selectees and at potential capital
providers.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Signing Authority
This document of the Department of
Energy was signed on February 28,
2024, by Giulia Siccardo, Director,
Office of Manufacturing and Energy
Supply Chains, pursuant to delegated
authority from the Secretary of Energy.
That document with the original
signature and date is maintained by
DOE. For administrative purposes only,
and in compliance with requirements of
the Office of the Federal Register, the
undersigned DOE Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
VerDate Sep<11>2014
17:45 Mar 01, 2024
Jkt 262001
official document of the Department of
Energy. This administrative process in
no way alters the legal effect of this
document upon publication in the
Federal Register.
Signed in Washington, DC, on February 28,
2024.
Treena V. Garrett,
Federal Register Liaison Officer,U.S.
Department of Energy.
[FR Doc. 2024–04508 Filed 3–1–24; 8:45 am]
BILLING CODE 6450–01–P
DEPARTMENT OF ENERGY
National Nuclear Security
Administration
Record of Decision for Adoption of
Nuclear Regulatory Commission’s
(NRC) Environmental Impact Statement
Related to the Operating License for
the SHINE Medical Isotope Production
Facility
National Nuclear Security
Administration, Department of Energy.
ACTION: Record of decision.
AGENCY:
The U.S. Department of
Energy’s National Nuclear Security
Administration (DOE/NNSA) intends to
issue a modification to its cooperative
agreement with SHINE Technologies,
DE–NA0004010, to revise the scope of
the agreement to include cost-shared
funding for facility construction.
Issuance of the modification is subject
to satisfactory completion of pricing and
other technical reviews. The
environmental impacts of this proposed
action have been addressed in the U.S.
Nuclear Regulatory Commission’s (NRC)
Environmental Impact Statement (EIS)
NUREG–2183 and NUREG–2183,
Supplement 1.
FOR FURTHER INFORMATION CONTACT: For
information on NNSA’s National
Environmental Policy Act (NEPA)
process, please contact Mr. James
Sanderson, NEPA Compliance Officer,
National Nuclear Security
Administration, Office of General
Counsel, at jim.sanderson@nnsa.doe.gov
or (202) 586–1402. This Record of
Decision is available at https://
energy.gov/nepa. The NRC EIS and
supplement are available at: https://
www.nrc.gov/reading-rm/doccollections/nuregs/staff/sr2183/
index.html (titles: NUREG–2183—
Environmental Impact Statement for the
Construction Permit for the SHINE
Medical Radioisotope Production
Facility Final Report and NUREG–2183,
Supplement 1, ‘‘Environmental Impact
Statement Related to the Operating
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
15565
License for the SHINE Medical Isotope
Production Facility’’ Final Report).
SUPPLEMENTARY INFORMATION: The U.S.
medical community depends on a
reliable supply of the radioisotope
molybdenum-99 (Mo–99) for nuclear
medical diagnostic procedures. Mo–99’s
decay product, technetium–99m (Tc–
99m), is used in over 40,000 medical
procedures in the United States each
day to diagnose heart disease and
cancer, to study organ structure and
function, and to perform other
important medical applications. In
2012, Congress passed the American
Medical Isotopes Production Act, which
directed NNSA to establish a
technology-neutral program to support
the establishment of domestic supplies
of Mo–99 without the use of highly
enriched uranium (HEU). NNSA has
implemented this by competitively
awarding 50/50 percent cost-shared
cooperative agreements to commercial
entities and providing funds to DOE’s
National Laboratories to support
development of non-HEU Mo–99
production technologies. Currently, the
scope of NNSA’s cooperative agreement
with SHINE Technologies includes
activities such as equipment
procurement but does not include
facility construction.
In 2015, the NRC and NNSA issued
NUREG–2183, ‘‘Environmental Impact
Statement for the Construction Permit
for the SHINE Medical Radioisotope
Production Facility’’ (NRC 2015), which
discussed the environmental impacts of
constructing, operating, and
decommissioning the SHINE Medical
Isotope Production Facility (SHINE
facility) in Janesville, Wisconsin. In
2016, at the conclusion of its safety and
environmental reviews, the NRC issued
a construction permit for the SHINE
facility (NRC 2016). In July 2019, SHINE
Medical Technologies, LLC (SHINE)
submitted to the NRC an application for
an operating license for the SHINE
facility. When a final environmental
impact statement (FEIS) has been
prepared in connection with the
issuance of a construction permit for a
facility, the NRC is required to prepare
a supplement to the FEIS in connection
with any issuance of an operating
license for that facility in accordance
with 10 Code of Federal Regulations
(CFR) 51.95(b). This supplement
updates the prior environmental review
and only covers matters that differ from
those or that reflect significant new
information relative to that discussed in
the FEIS. Accordingly, in response to
SHINE’s operating license application,
NRC and NNSA staff issued NUREG–
2183, Supplement 1, which considered
E:\FR\FM\04MRN1.SGM
04MRN1
15566
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
whether there is any new information
with respect to the environment or the
environmental impacts of the SHINE
facility, including information that is
different from that considered in
NUREG–2183. NRC staff did not
identify any information that presented
a considerably different picture of the
environmental consequences of
constructing, operating, and
decommissioning the SHINE facility.
After weighing the environmental,
economic, technical, and other benefits
against environmental and other costs,
NRC staff’s recommendation, unless
safety issues mandate otherwise, was
that the operating license be issued as
proposed. NRC staff based its
recommendation on the following: the
application, including SHINE’s
supplemental environmental report;
consultation with Federal, State, Tribal,
and local agencies; the staff’s
independent review; and the
consideration of public comments.
khammond on DSKJM1Z7X2PROD with NOTICES
Decision
NNSA intends to issue a modification
to its cooperative agreement with SHINE
Technologies, DE–NA0004010, to revise
the scope of the agreement to include
cost-share funding for facility
construction to support deployment of
this non-HEU Mo–99 production
technology. Issuance of the modification
is subject to satisfactory completion of
pricing and other technical reviews.
This modification reflects a reallocation
of funding previously awarded to DE–
NA0004010 and does not increase the
agreement’s total funding level.
Basis for Decision
The environmental impacts of this
proposed action have been previously
addressed in NUREG–2183,
‘‘Environmental Impact Statement for
the Construction Permit for the SHINE
Medical Radioisotope Production
Facility,’’ and NUREG–2183,
Supplement 1, ‘‘Environmental Impact
Statement Related to the Operating
License for the SHINE Medical Isotope
Production Facility.’’ NNSA was a
cooperating agency for both the EIS and
supplement and after an independent
review and determined that its
comments and suggestions were
satisfied per 40 CFR 1506.3(b)(2).
NNSA’s proposed action is substantially
the same as the proposed action
analyzed in NRC’s EIS and supplement.
Signing Authority
This document of the Department of
Energy was signed on January 31, 2024
by Jill Hruby, Under Secretary for
Nuclear Security and Administrator,
NNSA, pursuant to delegated authority
VerDate Sep<11>2014
18:32 Mar 01, 2024
Jkt 262001
from the Secretary of Energy. That
document with the original signature
and date is maintained by DOE. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
undersigned DOE Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of the Department of
Energy. This administrative process in
no way alters the legal effect of this
document upon publication in the
Federal Register.
Signed in Washington, DC, on February 27,
2024.
Treena V. Garrett,
Federal Register Liaison Officer, U.S.
Department of Energy.
[FR Doc. 2024–04397 Filed 3–1–24; 8:45 am]
BILLING CODE 6450–01–P
BILLING CODE 6717–01–P
Federal Energy Regulatory
Commission
DEPARTMENT OF ENERGY
Combined Notice of Filings
Take notice that the Commission has
received the following Natural Gas
Pipeline Rate and Refund Report filings:
Filings in Existing Proceedings
Docket Numbers: RP23–1032–001.
Applicants: Osaka Gas Trading &
Export LLC.
Description: Osaka Gas Trading &
Export LLC submits Annual Report of
Purchased Capacity pursuant to the
October 20, 2023 Order.
Filed Date: 2/26/24.
Accession Number: 20240226–5102.
Comment Date: 5 p.m. ET 3/11/24.
Docket Numbers: RP24–412–001.
Applicants: Guardian Pipeline, L.L.C.
Description: Tariff Amendment:
Amendment to Electric Power Cost
Recovery Surcharge Adjustment to be
effective 4/1/2024.
Filed Date: 2/23/24.
Accession Number: 20240223–5205.
Comment Date: 5 p.m. ET 3/6/24.
Any person desiring to protest in any
the above proceedings must file in
accordance with Rule 211 of the
Commission’s Regulations (18 CFR
385.211) on or before 5:00 p.m. Eastern
time on the specified comment date.
The filings are accessible in the
Commission’s eLibrary system (https://
elibrary.ferc.gov/idmws/search/
fercgensearch.asp) by querying the
docket number.
eFiling is encouraged. More detailed
information relating to filing
requirements, interventions, protests,
Frm 00026
Fmt 4703
Sfmt 4703
Dated: February 26, 2024.
Debbie-Anne A. Reese,
Acting Secretary.
[FR Doc. 2024–04417 Filed 3–1–24; 8:45 am]
DEPARTMENT OF ENERGY
PO 00000
service, and qualifying facilities filings
can be found at:https://www.ferc.gov/
docs-filing/efiling/filing-req.pdf. For
other information, call (866) 208–3676
(toll free). For TTY, call (202) 502–8659.
The Commission’s Office of Public
Participation (OPP) supports meaningful
public engagement and participation in
Commission proceedings. OPP can help
members of the public, including
landowners, environmental justice
communities, Tribal members and
others, access publicly available
information and navigate Commission
processes. For public inquiries and
assistance with making filings such as
interventions, comments, or requests for
rehearing, the public is encouraged to
contact OPP at (202) 502–6595 or OPP@
ferc.gov.
Federal Energy Regulatory
Commission
[Docket No. CP24–27–000]
Kern River Gas Transmission
Company; Notice of Staff Protest to
Proposed Blanket Certificate Activity
Federal Energy Regulatory
Commission (FERC or Commission) staff
(Protestor) hereby protests the prior
notice request filed under the provisions
of the Commission’s regulations at part
157, subpart F, by Kern River Gas
Transmission Company (Kern River) on
December 15, 2023, in the abovereferenced docket. Pursuant to its Part
157, subpart F, blanket certificate
authority, Kern River proposes to
construct and operate the Lanes
Crossing Meter Station (Project), within
Kern River’s existing Victorville Meter
Station at the High Desert Power Plant,
San Bernardino County, California.
Protestor seeks to have this prior notice
request processed as a case-specific
application filed under section 7(c) of
the Natural Gas Act (NGA) and Part 157,
subpart A, of the Commission’s
regulations.1
Protestor notes that Kern River did
not provide a copy of a finding by the
California State Historic Preservation
1 Section 157.205(f) provides that a protested
prior notice filing shall be treated as though it had
filed a case-specific application under NGA section
7, unless, pursuant to section 157.205(g), the
protestor withdraws its protest within 30 days after
protests were due.
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Pages 15565-15566]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04397]
-----------------------------------------------------------------------
DEPARTMENT OF ENERGY
National Nuclear Security Administration
Record of Decision for Adoption of Nuclear Regulatory
Commission's (NRC) Environmental Impact Statement Related to the
Operating License for the SHINE Medical Isotope Production Facility
AGENCY: National Nuclear Security Administration, Department of Energy.
ACTION: Record of decision.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Energy's National Nuclear Security
Administration (DOE/NNSA) intends to issue a modification to its
cooperative agreement with SHINE Technologies, DE-NA0004010, to revise
the scope of the agreement to include cost-shared funding for facility
construction. Issuance of the modification is subject to satisfactory
completion of pricing and other technical reviews. The environmental
impacts of this proposed action have been addressed in the U.S. Nuclear
Regulatory Commission's (NRC) Environmental Impact Statement (EIS)
NUREG-2183 and NUREG-2183, Supplement 1.
FOR FURTHER INFORMATION CONTACT: For information on NNSA's National
Environmental Policy Act (NEPA) process, please contact Mr. James
Sanderson, NEPA Compliance Officer, National Nuclear Security
Administration, Office of General Counsel, at
[email protected] or (202) 586-1402. This Record of Decision
is available at https://energy.gov/nepa. The NRC EIS and supplement are
available at: https://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr2183/ (titles: NUREG-2183--Environmental Impact
Statement for the Construction Permit for the SHINE Medical
Radioisotope Production Facility Final Report and NUREG-2183,
Supplement 1, ``Environmental Impact Statement Related to the Operating
License for the SHINE Medical Isotope Production Facility'' Final
Report).
SUPPLEMENTARY INFORMATION: The U.S. medical community depends on a
reliable supply of the radioisotope molybdenum-99 (Mo-99) for nuclear
medical diagnostic procedures. Mo-99's decay product, technetium-99m
(Tc-99m), is used in over 40,000 medical procedures in the United
States each day to diagnose heart disease and cancer, to study organ
structure and function, and to perform other important medical
applications. In 2012, Congress passed the American Medical Isotopes
Production Act, which directed NNSA to establish a technology-neutral
program to support the establishment of domestic supplies of Mo-99
without the use of highly enriched uranium (HEU). NNSA has implemented
this by competitively awarding 50/50 percent cost-shared cooperative
agreements to commercial entities and providing funds to DOE's National
Laboratories to support development of non-HEU Mo-99 production
technologies. Currently, the scope of NNSA's cooperative agreement with
SHINE Technologies includes activities such as equipment procurement
but does not include facility construction.
In 2015, the NRC and NNSA issued NUREG-2183, ``Environmental Impact
Statement for the Construction Permit for the SHINE Medical
Radioisotope Production Facility'' (NRC 2015), which discussed the
environmental impacts of constructing, operating, and decommissioning
the SHINE Medical Isotope Production Facility (SHINE facility) in
Janesville, Wisconsin. In 2016, at the conclusion of its safety and
environmental reviews, the NRC issued a construction permit for the
SHINE facility (NRC 2016). In July 2019, SHINE Medical Technologies,
LLC (SHINE) submitted to the NRC an application for an operating
license for the SHINE facility. When a final environmental impact
statement (FEIS) has been prepared in connection with the issuance of a
construction permit for a facility, the NRC is required to prepare a
supplement to the FEIS in connection with any issuance of an operating
license for that facility in accordance with 10 Code of Federal
Regulations (CFR) 51.95(b). This supplement updates the prior
environmental review and only covers matters that differ from those or
that reflect significant new information relative to that discussed in
the FEIS. Accordingly, in response to SHINE's operating license
application, NRC and NNSA staff issued NUREG-2183, Supplement 1, which
considered
[[Page 15566]]
whether there is any new information with respect to the environment or
the environmental impacts of the SHINE facility, including information
that is different from that considered in NUREG-2183. NRC staff did not
identify any information that presented a considerably different
picture of the environmental consequences of constructing, operating,
and decommissioning the SHINE facility. After weighing the
environmental, economic, technical, and other benefits against
environmental and other costs, NRC staff's recommendation, unless
safety issues mandate otherwise, was that the operating license be
issued as proposed. NRC staff based its recommendation on the
following: the application, including SHINE's supplemental
environmental report; consultation with Federal, State, Tribal, and
local agencies; the staff's independent review; and the consideration
of public comments.
Decision
NNSA intends to issue a modification to its cooperative agreement
with SHINE Technologies, DE-NA0004010, to revise the scope of the
agreement to include cost-share funding for facility construction to
support deployment of this non-HEU Mo-99 production technology.
Issuance of the modification is subject to satisfactory completion of
pricing and other technical reviews. This modification reflects a
reallocation of funding previously awarded to DE-NA0004010 and does not
increase the agreement's total funding level.
Basis for Decision
The environmental impacts of this proposed action have been
previously addressed in NUREG-2183, ``Environmental Impact Statement
for the Construction Permit for the SHINE Medical Radioisotope
Production Facility,'' and NUREG-2183, Supplement 1, ``Environmental
Impact Statement Related to the Operating License for the SHINE Medical
Isotope Production Facility.'' NNSA was a cooperating agency for both
the EIS and supplement and after an independent review and determined
that its comments and suggestions were satisfied per 40 CFR
1506.3(b)(2). NNSA's proposed action is substantially the same as the
proposed action analyzed in NRC's EIS and supplement.
Signing Authority
This document of the Department of Energy was signed on January 31,
2024 by Jill Hruby, Under Secretary for Nuclear Security and
Administrator, NNSA, pursuant to delegated authority from the Secretary
of Energy. That document with the original signature and date is
maintained by DOE. For administrative purposes only, and in compliance
with requirements of the Office of the Federal Register, the
undersigned DOE Federal Register Liaison Officer has been authorized to
sign and submit the document in electronic format for publication, as
an official document of the Department of Energy. This administrative
process in no way alters the legal effect of this document upon
publication in the Federal Register.
Signed in Washington, DC, on February 27, 2024.
Treena V. Garrett,
Federal Register Liaison Officer, U.S. Department of Energy.
[FR Doc. 2024-04397 Filed 3-1-24; 8:45 am]
BILLING CODE 6450-01-P
